Management of Ocular Toxicity in Patients Receiving Belantamab Mafodotin.

Lu, Rebecca; Morphey, Ashley; Diaz, Felicia; Chen, Jessica; Razmandi, Azadeh; Richards, Tiffany

Lu, Rebecca; Morphey, Ashley; Diaz, Felicia; Chen, Jessica; Razmandi, Azadeh; Richards, Tiffany.

Afiliação

Lu R; From The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morphey A; From The University of Texas MD Anderson Cancer Center, Houston, Texas.
Diaz F; From The University of Texas MD Anderson Cancer Center, Houston, Texas.
Chen J; From The University of Texas MD Anderson Cancer Center, Houston, Texas.
Razmandi A; From The University of Texas MD Anderson Cancer Center, Houston, Texas.
Richards T; From The University of Texas MD Anderson Cancer Center, Houston, Texas.

J Adv Pract Oncol ; 14(4): 300-306, 2023 May.

Article em En | MEDLINE | ID: mdl-37313276

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Adv Pract Oncol Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google